MIRA INFORM REPORT

 

 

Report Date :

08.02.2014

 

IDENTIFICATION DETAILS

 

Name :

BIOLAB SANUS FARMACEUTICA LTDA

 

 

Registered Office :

Avenida Paulo Ayres, 280 - Vila Iasi 06767-2020 - Taboão Da Serra/Sp

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

20.08.1978

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Subject Is Engaged In The Manufacture And Sale Of Pharmaceuticals In General; Veterinary Products, Nutritional Products And Cosmetics In General

 

 

No. of Employees :

1913

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

BRAZIL - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth to 2.7% in 2011, and 1.3% in 2012. Unemployment is at historic lows and Brazil's traditionally high level of income inequality has declined for each of the last 14 years. Brazil's historically high interest rates have made it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchange markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint. In an effort to boost growth, in 2012 the administration implemented a somewhat more expansionary monetary policy that has failed to stimulate much growth

 

Source : CIA

Company name and address

 

BIOLAB SANUS FARMACEUTICA LTDA

 

 

ADDRESSES

 

MAIN ADDRESS:

AVENIDA PAULO AYRES, 280 - VILA IASI

ZIP CODE/CITY:

06767-2020 - TABOÃO DA SERRA/SP

 

 

PHONE:

11 3573-6400

FAX:

11 3573-6400

E-MAIL:

furias@biolabfarma.com.br

WEB SITE:

www.biolabfarma.com.br

 

 

BRANCHES       

 

 

ADDRESS:

AVENIDA DOS BANDEIRANTES,5386

ZIP CODE/CITY:

04071-900 SÃO PAULO/SP

 

 

ADDRESS:

ESTRADA DE ITAPECERICA,23480

ZIP CODE/CITY:

05858-004 SÃO PAULO/SP

 

 

ADDRESS:

RUA OMAZ GARCIA PARRA,50

ZIP CODE/CITY:

06600-000 JANDIRA/SP

CNPJ:

494758330

 

 

ADDRESS:

AV. DO CAFE,277 703 TORRE B

ZIP CODE/CITY:

04311-000 SÃO PAULO/SP

 

 

ADDRESS:

RUA DAS OLIMPIADAS,242 / 3º ANDAR - VILA OLIMPIA

ZIP CODE/CITY:

04551-000 SÃO PAULO/SP

PHONE:

11 3573-6000

FAX:

11 3573-6065

CNPJ:

494758330

 

 

ADDRESS:

RUA SOLANGE APARECIDA MONTAN,49 - JARDIM SAGRADO CORAÇÃO

ZIP CODE/CITY:

06610-015 JANDIRA/SP

PHONE:

11 3573-6600

CNPJ:

49.475.833/0014-12

 

THE COMPANY ALSO HAS OTHER BRANCHES LOCATED IN: BRASILIA, RECIFE, GOIANIA, POUSO ALEGRE AND SÃO PAULO.

 

 

LEGAL DATA

 

MAIN ACTIVITIES

 

MANUFACTURE AND SALE OF PHARMACEUTICALS IN GENERAL; VETERINARY PRODUCTS, NUTRITIONAL PRODUCTS AND COSMETICS IN GENERAL.

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

20/08/1978

REGISTER DATE:

20/08/1978

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

49.475.833/0001-06

STATE REGISTER:

675.068.451.112

 

 

SHARE CAPITAL:

R$ 399.861.933,00

LAST REGISTER OF CAPITAL:

16/07/2013

 

 

BOARD OF DIRECTORS     

 

 

CLEITON DE CASTRO MARQUES

MANAGING PARTNER

DANTE ALÁRIO JÚNIOR

MANAGING PARTNER

PAULO DE CASTRO MARQUES

MANAGER

 

 

AUTHORIZED USE OF SIGNATURE

 

THE MANAGER AND MANAGING PARTNERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

PROVA PARTICIPAÇÕES LTDA

R$ 150.388.073,00

CLEITON DE CASTRO MARQUES

R$ 150.388.073,00

DANTE ALÁRIO JÚNIOR

R$ 99.085.787,00

 

AFFILIATES / SUBSIDIARIES:

 

 

 

A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR DIRECTORS HAS/HAVE THE FOLLOWING UNCONFIRMED HOLDINGS:

 

 

 MERZ-BIOLAB FARMACEUTICA COMERCIAL LTDA.

 

 COINFAR - CONSORCIO DE INDUSTRIAS FARMACEUTICAS

 

 COINFAR PESQUISA E DESENVOLVIMENTO FARMACEUTICO LTDA.

 

 SINTEFINA INDUSTRIA E COMERCIO LTDA

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON AUGUST 20, 1978 TO BE ENGAGED IN THE SAID LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN.

 

PREVIOUS CORPORATE NAMES:

- MAGRITT COMERCIO REPRESENTAÇÃO E DISTRIBUIDORA DE PRODUTOS QUIMICOS LTDA;

- MAGRITT INDUSTRIA FARMACEUTICA LTDA;

- SANUS FARMACEUTICA LTDA.

 

ON NOVEMBER 11, 2013 THE COMPANY TOOK OVER BIOLAB DERMOCOSMETICOS LTDA, CNPJ  01.539.361/0001-73.

 

PARTNERS:

 

PROVA PARTICIPAÇÕES LTDA, A LIMITED LIABILITY COMPANY, WITH HEAD OFFICE AT AVENIDA DO CAFÉ 277, TORRE A, 7ª, VILA GUARANI - SÃO PAULO/SP. HEREIN REPRESENTED BY ITS LEGAL REPRESENTATIVE MR. PAULO DE CASTRO MARQUES, BRAZILIAN, HOLDER OF DOCUMENTS, CPF # 860.267.048-68, RG # 7556065 SSP/SP, RESIDENTIAL ADDRESS AT AVENIDA DO CAFÉ 277, TORRE A, 7ª, VILA GUARANI - SÃO PAULO/SP;

 

CLEITON DE CASTRO MARQUES, BRAZILIAN, HOLDER OF DOCUMENTS, CPF # 860.267.398-15, RG # 8349370 SSP/SP, RESIDENTIAL ADDRESS AT AVENIDA DO CAFÉ 277, TORRE A, 7ª, VILA GUARANI - SÃO PAULO/SP;

 

DANTE ALÁRIO JÚNIOR, BRAZILIAN, HOLDER OF DOCUMENTS, CPF # 295.868.108-44, RG # 3465298 SSP/SP, RESIDENTIAL ADDRESS AT AVENIDA DO CAFÉ 277, TORRE A, 7ª, VILA GUARANI - SÃO PAULO/SP.

 

FURTHER DETAILS ARE SO FAR NOT KNOWN.

 

REMARKS:

--------

 

WHEN CONTACTING THE SUBJECT WE INTERVIEWED MR. FLAVIO, ACCOUNTING DEPARTMENT, WHO INFORMED THAT WOULD NOT DISCLOSE ANY KIND OF INFORMATION UNLESS THE INQUIRING PARTY'S NAME WAS DISCLOSED.

 

IF IT IS POSSIBLE TO DISCLOSE THE NAME OF THE INTERESTED SUPPLIER OF THE SUBJECT, WE MAY RESUME OUR CONTACTS AND TRY TO OBTAIN FURTHER INFORMATION.

 

THE DATA CONTAINED HEREIN WERE OBTAINED FROM OUTSIDE SOURCES, OUR DATABASE AND OFFICIAL. NO FURTHER DATA WAS AVAILABLE WITH SEVERAL SOURCES USUALLY INVESTIGATED.

 

 

PUBLIC INFORMATION

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

2

STATE LAWSUITS

12/03/13

VARA DE DF-BRASILIA

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2011 AND 31/12/2010.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2011

31/12/2010

 

 

 

 

 

CASH AND BANKS

204.519.896,65

211.841.140,15

 

CLIENTS

191.201.216,44

173.322.986,12

 

INVENTORY

54.314.404,80

40.276.975,30

 

RECOVERABLE TAXES

1.803.511,58

1.156.544,62

 

CREDIT WITH RELATED PARTIES

281.118,72

68.000,00

 

OTHER CREDITS

2.317.592,11

4.503.380,13

 

PRE PAID EXPENSES

5.359.615,79

4.849.080,80

 

 

----------------

----------------

 

TOTAL CURRENT ASSETS

459.797.356,09

436.018.107,12

 

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

INTERCOMPANY CREDITS

22.303.949,38

19.207.696,83

 

DEFERRED TAXES

4.718.868,72

5.609.389,24

 

RECOVERABLE TAXES

1.744.121,77

1.592.357,03

 

JUDICIAL DEPOSITS

2.028.868,00

1.941.224,76

 

 

----------------

----------------

 

TOTAL LONG-TERM RECEIVABLES

30.795.807,87

28.350.667,86

 

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

410.582,55

1.194.363,87

 

FIXED ASSETS

93.068.327,04

70.894.459,15

 

INTANGIBLE

18.720.199,25

19.015.812,00

 

 

----------------

----------------

 

TOTAL FIXED ASSETS

112.199.108,84

91.104.635,02

 

 

================

================

 

TOTAL ASSETS

602.792.272,80

555.473.410,00

 

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2011

31/12/2010

 

 

 

 

 

SUPPLIERS

8.947.362,98

7.919.934,14

 

FOREIGN SUPPLIERS

7.750.813,80

3.619.418,51

 

LOANS AND FINANCING

9.070.697,48

8.045.963,57

 

TRIBUTARY OBLIGATIONS

39.024.493,83

37.444.681,55

 

INCOME TAX/SOCIAL CONTRIBUTION

15.311.975,96

19.690.781,30

 

ACCOUNTS PAYABLE

3.402.305,76

3.617.389,45

 

PROFIT SHARING

3.818.308,18

23.186.182,43

 

 

----------------

----------------

 

TOTAL CURRENT LIABILITIES

87.325.957,99

103.524.350,95

 

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

487.382,10

780.054,85

 

DEFERRED TAXES

2.536.954,09

1.783.160,16

 

PROV. FOR UNCOVERED LIABILITY

636.253,50

47.327,52

 

PROVISION FOR CONTINGENCIES

4.593.160,96

6.185.399,40

 

 

----------------

----------------

 

TOTAL LONG TERM LIABILITIES

8.253.750,65

8.795.941,93

 

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

422.000.100,00

316.000.100,00

 

CAPITAL RESERVES

209.745,57

209.745,57

 

RESERVES FOR INVESTMENTS

943.271,55

40.219.065,40

 

ACCRUED PROFIT (LOSS)

84.059.447,04

86.724.206,15

 

 

----------------

----------------

 

TOTAL NET EQUITY

507.212.564,16

443.153.117,12

 

 

================

================

 

TOTAL LIABILITIES

602.792.272,80

555.473.410,00

 

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2011 AND 31/12/2010.

( FIGURES ARE IN REAIS ).

 

 

31/12/2011

31/12/2010

 

 

 

 

 

GROSS SALES

661.820.826,37

617.024.667,04

 

(-) TAXES ON SALES

83.027.020,82

77.858.776,31

 

 

----------------

----------------

 

NET SALES

578.793.805,55

539.165.890,73

 

(-) COST OF SOLD GOODS

129.948.023,51

108.396.088,29

 

 

----------------

----------------

 

GROSS PROFIT

448.845.782,04

430.769.802,44

 

OPERATING REVENUE (EXPENSE)

-343.954.890,80

-292.306.375,38

 

FINANCIAL REVENUE(EXPENSE)

21.089.517,88

-4.597.860,62

 

 

----------------

----------------

 

OPERATIONAL PROFIT (LOSS)

125.980.409,12

133.865.566,44

 

NON-OPERATING RESULT

69.618,13

-564.829,32

 

CONTRIBUTION/INCOME TAX

-41.990.580,21

-46.576.530,97

 

 

----------------

----------------

 

NET PROFIT (LOSS)

84.059.447,04

86.724.206,15

 

 

RATIOS:

31/12/2011

31/12/2010

 

 

QUICK RATIO

4,64

 

3,82

 

 

 

CURRENT RATIO

5,27

 

4,21

 

 

 

ACCOUNTS RECEIVABLE TURNOVER

3,03

TIMES

3,11

TIMES

 

 

DAYS' SALES IN RECEIVABLES

118,92

DAYS

115,73

DAYS

 

 

INVENTORY TURNOVER

2,39

TIMES

2,69

TIMES

 

 

ACCOUNTS PAYABLE PERIOD

24,79

DAYS

26,30

DAYS

 

 

RETURN ON ASSETS

,96

TIMES

,97

TIMES

 

 

SALES TURNOVER ON NET EQUITY

1,14

TIMES

1,22

TIMES

 

 

NET WORTH TIE-UP

,18

 

,16

 

 

 

INDEBTEDNESS

,19

 

,25

 

 

 

EQUITY RATIO

84,14

%

79,78

%

 

 

WORKING CAPITAL RATIO

426,53

%

321,17

%

 

 

GENERAL SOLVENCY

6,31

 

4,95

 

 

 

RETURN ON NET EQUITY

16,57

%

19,57

%

 

 

RETURN ON SALES (PROFIT MARGIN)

14,52

%

16,08

%

 

 

GROSS PROFIT MARGIN

77,55

%

79,90

%

 

 

OPERATIONAL RESULT

21,77

%

24,83

%

 

 

SALES TURNOVER ON LIABILITIES

6,63

TIMES

5,21

TIMES

 

 

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 2,41

 - OFFICIAL RATE ON 04/02/2014

US$ 1,00 = R$ 1,87

 - OFFICIAL RATE ON 31/12/2011

US$ 1,00 = R$ 1,67

 - OFFICIAL RATE ON 31/12/2010

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE ANNUAL FIGURES AVAILABLE SHOWED A VERY GOOD FINANCIAL STANDING. IT WAS NOTED HIGH LIQUIDITY RATIOS AND HIGH WORKING CAPITAL, AS WELL AS LOW LEVEL OF INDEBTEDNESS. IT ALSO SHOWS GROWING SALES AND HIGH PROFITABILITY.

 

 

REAL ESTATE:

 

   NOT AVAILABLE

 

 

VEHICLES:

 

   NOT AVAILABLE

 

MACHINES:

 

   NOT AVAILABLE

 

 

INSURANCE

 

INSURANCE COMPANY:

ACE SEGURADORA S/A (HEADQUARTER)

COVERAGE:

FIRE

EXPIRATION:

NOT AVAILABLE

VALUE:

R$ 50.000.000,00

 

 

INSURANCE COMPANY:

ACE SEGURADORA S/A (BRANCHES)

COVERAGE:

FIRE

EXPIRATION:

NOT AVAILABLE

VALUE:

R$ 1.500.000,00

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO ITAÚ S/A

11 3708-8558

 

BANCO DO BRASIL S/A

11 2128-7189

 

BANCO ITAUBANK S/A

11 3398-6053

 

BANCO SAFRA S/A

11 3178-2205

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE MANUFACTURE AND SALE OF PHARMACEUTICALS IN GENERAL; VETERINARY PRODUCTS, NUTRITIONAL PRODUCTS AND COSMETICS IN GENERAL.

 

 

 

 

IMPORT AND EXPORT:

 

   IMPORTS FROM:

 

CHINA, INDIA, GERMANY, FRANCE, AND SWITZERLAND.

 

 EXPORTS TO:

DOMINICAN REPUBLIC (THE)

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

 

PHONE:

AUDIFAR COML. LTDA

 

 

DISTRIB. DE MED. STA. CRUZ LTDA

 

 

DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS PANARELLO

 

62 285-6633

DROGARIA SÃO PAULO S/A

 

 

ITA REPRES. PROD. FARMACEUTICOS S/A

 

 

MERCANTIL FARMED LTDA

 

11 839-5600

PROFARMA DISTRIB DE PRODUTOS FARMACÊUTICOS LTDA

 

21 450-1828

SAGRA PRODUTOS FARMACÊUTICOS

 

16 627-2009

 

STAFF:

 

THE COMPANY HAS: 1913 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS AN OLD AND WELL-ESTABLISHED COMPANY, OPERATING SINCE 1978. SO FAR IT HAS A CLEAR TRADE HISTORY AND GOOD PAYMENT BEHAVIOR. IT IS A FAMILY-RUN COMPANY AND BOTH THE COMPANY AND THE PRINCIPALS ENJOY A FAVORABLE REPUTATION AMONG LOCAL TRADE SOURCES.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

THE LAWSUITS REPORTED ARE NOT RELATED WITH TRADE DEBTS. THEY ARE RELATED TO TAX DEBTS THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUITS DO NOT AFFECT THE COMPANY'S TRADE REPUTATION.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

PHONE:

ALCAN PACKAGING DO BRASIL LTDA

 

11 4075-6500

ALTEC COM. IND. TAMPAS METÁLICAS LTDA

 

 

BAFEMA S/A

 

11 5666-9088

BILLI FAMACÊUTICA LTDA

 

11  536-3688

EUROFARMA LABORATÓRIOS LTDA

 

11 5693-4100

FAMACAP IND. E COMERCIO LTDA

 

11 4666-5333

GENIX IND. FARMAC. LTDA

 

 

IMPACTA AS IND E COMERCIO

 

11 4447-7322

SCHOTT VITROSUL LTDA

 

11 4591-0246

SELECTCHEMIE IMP. E EXP. E REPRES. LTDA

 

11 5581-6668

TUBOCAP ARTEFATOS DE METAL LTDA

 

 

VEDAT TAMPAS HERMÉTICAS LTDA

 

11  494-4266

WHEATON DO BRASIL INDUSTRIA E COMERCIO

 

11 5584-5133

 

FOREIGN SUPPLIERS:

COUNTRY:

 

DIOSYNTH B.V.

HOLLAND

 

DR. REDDY S LABORATORIES LTD

INDIA

 

EFFECHEM SRL

ITALY

 

MERZ + CO GMBH & CO

GERMANY

 

 

PAYMENT HISTORY:

 

17 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 177.485,00

 

AMOUNT OF INVOICES PAID: 35

TOTAL OF PROMPT PAYMENTS: 100%

HIGHEST INVOICE: R$ 47.496,00

HIGHEST CREDIT: R$ 47.496,00

 

 

FINAL OPINION

 

THE SUBJECT IS AN OLD AND WELL-ESTABLISHED COMPANY, IT HAS A VERY GOOD FINANCIAL STANDING, A CLEAR TRADE HISTORY AND GOOD PAYMENT PERFORMANCE.

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

AN INITIAL CREDIT LIMIT OF USD 5.000.000,00 MAY BE CONSIDERED. EVEN HIGHER AMOUNTS CAN BE GRANTED DEPENDING ON THE IMPORTANCE OF THE ACTIVITIES BEING ESTABLISHED WITH THE SUBJECT.

 

 

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.62.32

UK Pound

1

Rs.101.78

Euro

1

Rs.84.68

 

 

INFORMATION DETAILS

 

Report Prepared by :

NIS

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.